Almirall signs atopic dermatitis R&D deal with HitgenAlmirall has signed a new research collaboration with Chinese biotech HitGen, to find potential new oral therapies for Share XAlmirall signs atopic dermatitis R&D deal with Hitgenhttps://pharmaphorum.com/news/almirall-signs-atopic-dermatitis-rd-deal-with-hitgen/
NICE okays UCB’s Cimzia, nixes Almirall’s Ilumetri, in psoriasisNICE has recommended in draft guidance that UCB’s Cimzia can receive regular NHS funding for plaque psoriasis, but Share XNICE okays UCB’s Cimzia, nixes Almirall’s Ilumetri, in psoriasishttps://pharmaphorum.com/news/nice-okays-ucbs-cimzia-nixes-almirall-ilumetri-in-psoriasis/
Almirall buys Allergan’s derma portfolioAlmirall is expanding its business by buying Allergan’s dermatology portfolio. The Spanish pharma company will buy five brands Share XAlmirall buys Allergan’s derma portfoliohttps://pharmaphorum.com/news/almirall-buys-allergans-derma-portfolio/
